U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036003) titled 'Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)' on May 30.
Brief Summary: The goal of this clinical trial is to see if people with knee osteoarthritis would be willing to comply and adhere to incorporating Recombinant Human Growth Hormone (rHGH), specifically Saizen Somatropin solution, into their treatment plan.
Participants will be asked to:
* Self-inject the treatment solution (placebo or somatropin) into the abdominal or gluteal area twice per day for a total of 6 weeks.
* Complete questionnaires related to their knee pain and activities of daily living.
* Provide blood tests.
* Complete various meas...